Therapeutics of Alzheimer's disease: Past, present and future.
about
Long noncoding RNAs and Alzheimer's diseaseBiomaterials for the Treatment of Alzheimer's DiseaseOne for All? Hitting Multiple Alzheimer's Disease Targets with One DrugAn overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsAlzheimer's Disease: Mechanism and Approach to Cell TherapyVitamin D and Alzheimer's Disease: Neurocognition to TherapeuticsNeuroinflammation in Alzheimer's diseaseDihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer's Disease.Interferon Gamma: Influence on Neural Stem Cell Function in Neurodegenerative and Neuroinflammatory DiseaseMedicinal properties of Hericium erinaceus and its potential to formulate novel mushroom-based pharmaceuticalsNorovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer's disease.Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.Web-based cognitive training: patient adherence and intensity of treatment in an outpatient memory clinicOverexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer's diseaseCorrelation between overactive bladder symptom score and neuropsychological parameters in Alzheimer's disease patients with lower urinary tract symptom.AlzhCPI: A knowledge base for predicting chemical-protein interactions towards Alzheimer's disease.Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways.The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?Bioinformatics methods in drug repurposing for Alzheimer's disease.Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice.New approaches to treating Alzheimer's diseaseChitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.The discovery of new acetylcholinesterase inhibitors derived from pharmacophore modeling, virtual screening, docking simulation and bioassays.Microglial Inhibitory Mechanism of Coenzyme Q10 Against Aβ (1-42) Induced Cognitive Dysfunctions: Possible Behavioral, Biochemical, Cellular, and Histopathological Alterations.Imaging the accumulation and suppression of tau pathology using multiparametric MRI.Fucoxanthin, a Marine Carotenoid, Reverses Scopolamine-Induced Cognitive Impairments in Mice and Inhibits Acetylcholinesterase in VitroCognitive-enhancing effects of hydrolysate of polygalasaponin in SAMP8 miceFus1 KO Mouse As a Model of Oxidative Stress-Mediated Sporadic Alzheimer's Disease: Circadian Disruption and Long-Term Spatial and Olfactory Memory ImpairmentsVitamin D supplements: a novel therapeutic approach for Alzheimer patients.Deep Phosphoproteomic Measurements Pinpointing Drug Induced Protective Mechanisms in Neuronal Cells.Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota.Poor Gait Performance and Prediction of Dementia: Results From a Meta-Analysis.Icariside II Effectively Reduces Spatial Learning and Memory Impairments in Alzheimer's Disease Model Mice Targeting Beta-Amyloid Production.Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.Tau-based therapeutic approaches for Alzheimer's disease - a mini-review.Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.Animal models of source memory.Benefits and risks of add-on therapies for Alzheimer's disease.Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae).Alzheimer's Disease and ncRNAs.
P2860
Q26740231-48B39EC1-7432-4D29-AB47-9BAC7BBDB080Q26744462-9BACA8DB-8FF8-4A72-BA73-71673241F21AQ26747572-63653FC5-A0C5-4884-9AEE-99D92AACB6B9Q26751302-BA1FC703-7E54-43AA-ABD2-E36BB08713ACQ26778149-28FF086E-99FD-47BF-B68B-96FDACB389EFQ26782403-EFA656D8-31D1-4994-BFC8-0B9C86C7E15AQ27004226-F996225B-770F-4C85-A2D6-C1B1568BECACQ27333755-D8B3D4E9-4876-49B3-B78F-FD0907290001Q27928023-0E5CECF2-B1A7-49FD-AE00-6E02D89978D1Q29026697-14A11C69-638E-496B-BEA4-F88E33436384Q30835636-CAC3FEDB-BA34-440E-BFA1-C12CB578BD2FQ31124464-7427F685-CB52-4D6F-899D-509804319021Q33664806-BCF88C75-F2CB-4C2C-BC86-247BCFA1EC1BQ33677609-19EFADA4-D62A-4B09-B14C-86622D7EE257Q33692634-0D703B6D-2F60-48C2-8B83-0F8417B57647Q33769352-42FC7A9D-7092-4044-A6FD-524663828714Q33825472-86B560A3-5D5E-4D9D-9226-0882728D6762Q34426210-D5055189-FBF9-4336-82BF-205A3929F752Q34486241-DC7B502F-BC7F-4BF2-B044-4AD922DE1C39Q34794030-1399CB0C-C69E-4A74-94AC-03925DCB5F11Q35081742-508F32E3-C530-4E42-A6F7-F7D907B5F81DQ35640608-37F411A2-CB0A-4F68-A0C8-BE0646A644AAQ36179047-63E802CA-E0D5-4701-BEC7-42B5E3C78ACBQ36260932-921B3AD2-45A3-4484-9199-1262926376A5Q36663462-4B5680EA-186D-4E32-8FAA-34B8BF8DA746Q36847332-FD892F04-7BFE-49D1-B20C-2E6BD212DE3AQ37084562-AF4C3C5D-C362-4ACA-B1F8-E7CD38F4B90EQ37413462-810B60FD-731A-4C68-A61B-7552E155EA4BQ37522446-3FD98E2E-F9F3-4D01-A20A-05CB3CAD04E3Q37528700-446F7937-01CE-4EA6-92AD-49EA2F0C5306Q37631109-9E4627ED-ECB2-42B8-99C0-742524A9474FQ37656470-13A699F7-2169-4DC6-BE1A-F6A0C6C96928Q37685356-7A8DA77A-4E8B-4311-9F29-6C6E484452AAQ37739881-E911D450-D8C5-4A72-B6CD-AD06D25E3413Q38204620-9986DA5F-40F1-4DFC-9DB1-063A146167B5Q38286222-0C1C43CC-8FD0-485E-802A-9EA975563374Q38546810-69C147D6-D4F3-4D93-9598-AD405C423E17Q38620338-348A3F98-A6DE-44E5-8797-8C85F3514EFDQ38679235-63BDD786-ABA9-437E-9C92-EC6661B13289Q38681920-712897A7-4ABA-4ECC-8ADF-9D09C8BFABC5
P2860
Therapeutics of Alzheimer's disease: Past, present and future.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutics of Alzheimer's disease: Past, present and future.
@en
type
label
Therapeutics of Alzheimer's disease: Past, present and future.
@en
prefLabel
Therapeutics of Alzheimer's disease: Past, present and future.
@en
P2093
P1433
P1476
Therapeutics of Alzheimer's disease: Past, present and future.
@en
P2093
Abbas Ali Mahdi
Kiran Dip Gill
P356
10.1016/J.NEUROPHARM.2013.07.004
P478
P577
2013-07-25T00:00:00Z